These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18306360)

  • 1. Mutations are no substitutes for clotting, chromogenic and immunological assays in patients with congenital prothrombin deficiency.
    Girolami A; Scarparo P; Allemand E
    Am J Hematol; 2008 Jun; 83(6):518; author reply 518-9. PubMed ID: 18306360
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias.
    Girolami A; Patrassi G; Toffanin F; Saggin L
    Am J Clin Pathol; 1980 Jul; 74(1):83-7. PubMed ID: 7395819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital factor II deficiency: moroccan cases.
    Imane S; Laalej Z; Faez S; Oukkache B
    Int J Lab Hematol; 2013 Aug; 35(4):416-20. PubMed ID: 23190616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin Suresnes: a case of homozygous F299V mutation responsible for hypodysprothrombinemia.
    François D; Chevreaud C; Vignon D; de Mazancourt P
    Haematologica; 2006 Mar; 91(3):431-2. PubMed ID: 16503555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin Saint-Denis: a natural variant with a point mutation resulting in Asp to Glu substitution at position 552 in prothrombin.
    Rouy S; Vidaud D; Alessandri JL; Dautzenberg MD; Venisse L; Guillin MC; Bezeaud A
    Br J Haematol; 2006 Mar; 132(6):770-3. PubMed ID: 16487178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital prothrombin deficiency.
    Lancellotti S; De Cristofaro R
    Semin Thromb Hemost; 2009 Jun; 35(4):367-81. PubMed ID: 19598065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency.
    Girolami A; Candeo N; Vettore S; Lombardi AM; Girolami B
    J Thromb Thrombolysis; 2010 Apr; 29(3):299-302. PubMed ID: 19412729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin Mumbai causes severe prothrombin deficiency due to a novel Cys90Ser mutation.
    Kulkarni B; Kanakia S; Ghosh K; Shetty S
    Ann Hematol; 2012 Oct; 91(10):1667-8. PubMed ID: 22392504
    [No Abstract]   [Full Text] [Related]  

  • 10. A severe neonatal presentation of factor II deficiency.
    Pasmant E; Dumont B; Lacapere JJ; Dautzenberg MD; Bezeaud A
    Eur J Haematol; 2011 Nov; 87(5):464-6. PubMed ID: 21692854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital deficiencies and abnormalities of prothrombin.
    Girolami A; Scarano L; Saggiorato G; Girolami B; Bertomoro A; Marchiori A
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):557-69. PubMed ID: 9863703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin deficiency caused by compound heterozygosity for two novel mutations in the prothrombin gene associated with a bleeding tendency.
    Stanchev H; Philips M; Villoutreix BO; Aksglaede L; Lethagen S; Thorsen S
    Thromb Haemost; 2006 Jan; 95(1):195-8. PubMed ID: 16543981
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic administration of prothrombin complex concentrates for congenital prothrombin deficiency with a novel frameshift mutation, prothrombin saitama.
    Seki M; Koh K; Inoue T; Tomita Y; Kato M; Shimizu M; Morishita E; Hanada R
    Pediatr Blood Cancer; 2013 Mar; 60(3):503-5. PubMed ID: 23152198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. True congenital prothrombin deficiency due to a 'new' mutation in the pre-propeptide (ARG-39 GLN).
    Girolami A; Santarossa L; Scarparo P; Candeo N; Girolami B
    Acta Haematol; 2008; 120(2):82-6. PubMed ID: 18852482
    [No Abstract]   [Full Text] [Related]  

  • 15. [Familial deficiency of factor X].
    Gonzalo GB; Lucia RO; Alejandro VG; Pablo LV
    Sangre (Barc); 1973; 18(2):178-89. PubMed ID: 4753556
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
    Meeks SL; Abshire TC
    Haemophilia; 2008 Nov; 14(6):1159-63. PubMed ID: 19141155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel mutations in the prothrombin gene identified in a patient with compound heterozygous type 1/2 prothrombin deficiency.
    Kuijper PH; Schellings MW; van de Kerkhof D; Nicolaes GA; Reitsma P; Halbertsma F; Dors N
    Haemophilia; 2013 Sep; 19(5):e304-6. PubMed ID: 23711336
    [No Abstract]   [Full Text] [Related]  

  • 18. Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy.
    Strijks E; Poort SR; Renier WO; Gabreëls FJ; Bertina RM
    Neuropediatrics; 1999 Dec; 30(6):320-4. PubMed ID: 10706027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the carrier state in congenital "true" prothrombin deficiency.
    Girolami A; Dal Bo Zanon R
    Am J Hematol; 1988 Apr; 27(4):306-7. PubMed ID: 3354565
    [No Abstract]   [Full Text] [Related]  

  • 20. [Constitutional and acquired dysprothrombinemias].
    Josso F; Lavergne JM; Soulier JP
    Nouv Rev Fr Hematol; 1970; 10(5):633-44. PubMed ID: 4250286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.